North America Wound Care Biologics Market - Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

North America Wound Care Biologics Market_Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

North America wound care biologics market is expected to grow with a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases, rising number of geriatric population, innovation in wound care biologics are fuel the growth of wound care biologics market.

The key market players for North America wound care biologics market are listed below:

• Integra LifeSciences
• ConvaTec Inc.
• AlloSource
• Amniox Medical, Inc.
• Marine Polymer Technologies, Inc.
• Solsys Medical
• ACell Inc.
• Kerecis
• WRIGHT MEDICAL GROUP N.V.
• Vericel Corporation
• Anika Therapeutics, Inc.
• Skye Biologics Inc.
• BioHorizons IPH, Inc
• Alphatec Spine, Inc.
• Amnio Technology, LLC
• Mölnlycke Health Care AB
• Smith and Nephew
• MiMedx
• Organogenesis Inc.
• Osiris Therapeutics, Inc.

The North America wound care biologics market is segmented into:
• Product Type
• Wound Type
• End User

On the basis of product type the North America wound care biologics market is segmented into synthetic skin grafts segment, growth factors segment, allografts segment, xenografts segment. In 2018, synthetic skin grafts segment is expected to dominate the North America wound care biologics market with highest market shares. However, allografts segment is expected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF) segment, platelet rich plasma (PRP) segment, epidermal growth factor (EGF) segment and basic fibroblast growth factor (BFGF) segment, granulocyte colony stimulating factor (G-CSF), talactoferrin alfa segment, thrombin peptide (TP508) segment, keratinocyte growth factor (KGF) segment.

On the basis of wound type the North America wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segment is expected to dominate the North America wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.

On the basis of end user North America wound care biologics market is segmented into hospitals, wound care centres and ambulatory centres, clinics, community healthcare centers. In 2018, hospitals are expected to dominate the North America wound care biologics market with the highest CAGR in the forecast period 2018 to 2025.

Based on geography, the market is segmented into 3 geographical regions:
• U.S.
• Canada
• Mexico

Covered in this report

The report covers the present scenario and the growth prospects of the North America wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of North America Wound Care Biologics Market
1.4 Currency And Pricing
1.5 Limitation
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.1 Dbmr Market Position Grid
2.2 Dbmr Market Challenge Matrix
2.3 Secondary Sources
2.4 Assumptions
3 Market Overview
3.1 Drivers
3.1.1 Increasing Cases Of Diabetic Foot Ulcers
3.1.2 Increasing Incidences Of Burn Cases
3.1.3 Rising Number Of Geriatric Population
3.1.4 Innovation In Wound Care Biologics
3.1.5 New Product Launches
3.2 Restrains
3.2.1 High Cost Of Wound Treatment And Wound Care Biologics
3.2.2 Risk Of Skin Substitue Failure
3.3 Opportunities
3.3.1 3D Skin Printing
3.3.2 Awareness Programs
3.4 Challenges
3.4.1 Lack Of Wound Management Services
4 Executive Summary
5 Premium Insights
6 North America Wound Care Biologics Market, By Product Type
6.1 Overview
6.2 Synthetic Skin Grafts
6.3 Growth Factors
6.3.1 Platelet Derived Growth Factor (Pdgf)
6.3.2 Platelet Rich Plasma (Prp)
6.3.3 Epidermal Growth Factors (Egf)
6.3.4 Basic Fibroblast Growth Factors (Bfgf)
6.3.5 Granulocyte Colony Stimulating Factor (G-Csf)
6.3.6 Talactoferrin Alfa
6.3.7 Thrombin Peptide
6.3.8 Keratinocy Growth Factor (Kgf)
6.4 Allografts
6.5 Xenografts
7 North America Wound Care Biologics Market, By Wound Type
7.1 Overview
7.2 Wounds
7.2.1 Surgical Wound
7.2.1.1 Skin Surgery
7.2.1.1.1 Wound Closure
7.2.1.1.2 Skin Biopsy
7.2.1.1.3 Skin Flap
7.2.1.1.4 Skin Graft
7.2.1.1.5 Others
7.2.1.2 Cosmetic Procedure
7.2.1.2.1 Brest Enhancement
7.2.1.2.2 Facial Contouring
7.2.1.2.3 Facial Rejuvenation:
7.2.1.2.4 Body Contouring
7.2.1.2.5 Skin Rejuvenation
7.2.1.2.6 Others
7.2.1.3 Gynecologic Procedures
7.2.1.3.1 Pubovaginalis Sling
7.2.1.3.2 Pelvic Floor Reconstruction
7.2.1.3.3 Rectocele Repair Surgery
7.2.1.3.4 Others
7.2.1.4 Gastrointestinal Procedure
7.2.1.4.1 General Gastrointestinal Surgery
7.2.1.4.2 Hernia
7.2.1.4.3 Others
7.2.2 Acute Wounds
7.2.3 Chronic Wounds
7.2.4 Traumatic Wounds
7.3 Burns
7.3.1 Ulcers
7.3.2 Diabetic Ulcers
7.3.3 Pressure Ulcer
7.3.4 Venous Ulcer
7.3.5 Others
8 North America Wound Care Biologics Market, By End User
8.1 Overview
8.2 Hospitals
8.3 Wound Care Centers
8.4 Ambulatory Surgical Centers
8.5 Clinics
8.6 Community Healthcare Center
9 North America Wound Care Biologics Market: Geography
9.1 North America
9.1.1 U.S.
9.1.2 Canada
9.1.3 Mexico
10 North America Wound Care Biologics Market, Company Landscape
10.1 Company Share Analysis: North America
11 Company Profile
11.1 Mimedx.
11.1.1 Company Overview
11.1.2 Revenue Analysis:
11.1.3 Company Share Analysis:
11.1.4 Product Portfolio
11.1.5 Recent Developments
11.2 Organogenesis Inc
11.2.1 Company Overview
11.2.2 Geographic Presence
11.2.3 Company Share Analysis:
11.2.4 Product Portfolio
11.2.5 Recent Developments
11.3 Integra Lifesciences
11.3.1 Company Overview
11.3.2 Revenue Analysis
11.3.3 Company Share Analysis:
11.3.4 Product Portfolio
11.3.5 Recent Developments
11.4 Convatec Inc.
11.4.1 Company Overview
11.4.2 Revenue Analysis
11.4.3 Company Share Analysis:
11.4.4 Product Portfolio :
11.4.5 Recent Developments
11.5 Acell Inc.
11.5.1 Company Overview
11.5.2 Product Portfolio
11.5.3 Recent Developments
11.6 Allosource
11.6.1 Company Overview
11.6.2 Product Portfolio
11.6.3 Recent Developments
11.7 Alphatec Spine, Inc. ( A Subsidary Of Alphatec Holdings, Inc)
11.7.1 Company Overview
11.7.2 Product Portfolio
11.7.3 Recent Developments
11.8 Amnio Technology, Llc
11.8.1 Company Overview
11.8.2 Product Portfolio
11.8.3 Recent Developments
11.9 Amniox Medical, Inc.
11.9.1 Company Overview
11.9.2 Product Portfolio
11.9.3 Recent Developments
11.10 Anika Therapeutics, Inc.
11.10.1 Company Overview
11.10.2 Revenue Analysis
11.10.3 Product Portfolio
11.10.4 Recent Developments
11.11 Biohorizons Iph, Inc ( A Subsidary Of Henry Schein, Inc.)
11.11.1 Company Overview
11.11.2 Geographicpresence
11.11.3 Product Portfolio
11.11.4 Recent Developments
11.12 Kerecis
11.12.1 Company Overview
11.12.2 Geographical Presence
11.12.3 Product Portfolio
11.12.4 Recent Developments
11.13 Marine Polymer Technologies, Inc
11.13.1 Company Overview
11.13.2 Product Portfolio
11.13.3 Recent Developments
11.14 Mölnlycke Health Care Ab
11.14.1 Company Overview
11.14.2 Revenue Analysis
11.14.3 Product Portfolio
11.14.4 Recent Developments
11.15 Osiris Therapeutics, Inc.
11.15.1 Company Overview
11.15.2 Revenue Analysis
11.15.3 Product Portfolio
11.15.4 Recent Developments
11.16 Skye Biologics Inc.
11.16.1 Company Overview
11.16.2 Product Portfolio :
11.16.3 Recent Development:
11.17 Smith And Nephew
11.17.1 Company Overview
11.17.2 Revenue Analysis
11.17.3 Product Portfolio
11.17.4 Recent Developments
11.18 Solsys Medical.
11.18.1 Company Overview
11.18.2 Product Portfolio
11.18.3 Recent Developments
11.19 Vericel Corporation.
11.19.1 Company Overview
11.19.2 1.1.2 Revenue Analysis
11.19.3 Product Portfolio
11.19.4 Recent Developments
11.20 Wright Medical Group N.V
11.20.1 Company Overview
11.20.2 1.1.2 Revenue Analysis
11.20.3 Product Portfolio
11.20.4 Recent Developments
12 Related Reports
List Of Tables
Table 1 North America Wound Care Biologics Market, By Product Type, 2016– 2025 (Usd Million)
Table 2 North America Synthetic Skin Grafts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 3 North America Growth Factors In Wound Care Biologics Market, By Product Type, 2016– 2025 (Usd Million)
Table 4 North America Growth Factors In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 5 North America Allografts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 6 North America Xenografts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 7 North America Wound Care Biologics Market, By Wound Type, 2015– 2025 (Usd Million)
Table 8 North America Wounds In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 9 North America Wounds In Wound Care Biologics Market, By Wound Type, 2016– 2025 (Usd Million)
Table 10 North America Surgical Wound In Wound Care Biologics Market, 2016-2025 (Usd Million)
Table 11 North America Skin Surgery In Wound Care Biologics Market, 2016-2025 (Usd Million)
Table 12 Number Of Cosmetic Surgery, 2016 & 2017
Table 13 North America Cosmetic Surgery In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million)
Table 14 North America Gynecologic Procedures In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million)
Table 15 North America Gastrointestinal Procedures In Wound Care Biologics Market, By Wound Type 2018-2025 (Usd Million)
Table 16 North America Burns In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 17 North America Ulcers In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 18 North America Ulcers In Wound Care Biologics Market, By Wound Type 2016-2025 (Usd Million)
Table 19 North America Wound Care Biologics Market, By End User, 2016 – 2025 (Usd Million)
Table 20 North America Hospitals In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 21 North America Wound Care Center In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 22 Statistics For Ambulatory Surgical Center. U.S.
Table 23 North America Ambulatory Surgical Centers In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 24 North America Clinics In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 25 North America Community Healthcare Center In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 26 North America Wound Care Biologics Market, By Country, 2016-2025 (Usd Million )
Table 27 North America Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 28 North America Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 29 North America Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 30 North America Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 31 North America Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 32 North America Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 33 North America Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 34 North America Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 35 North America Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 36 North America Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 37 North America Wound Care Biologics, By End User, 2016-2025, (Usd Million)
Table 38 U.S. Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 39 U.S. Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 40 U.S. Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 41 U.S. Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 42 U.S. Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 43 U.S. Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 44 U.S. Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 45 U.S. Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 46 U.S. Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 47 U.S. Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 48 U.S. Wound Care Biologics, By End User, 2016-2025, (Usd Million)
Table 49 Canada Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 50 Canada Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 51 Canada Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 52 Canada Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 53 Canada Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 54 Canada Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 55 Canada Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 56 Canada Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 57 Canada Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 58 Canada Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 59 Canada Wound Care Biologics, By End User, 2016-2025, (Usd Million)
Table 60 Mexico Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 61 Mexico Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 62 Mexico Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 63 Mexico Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 64 Mexico Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 65 Mexico Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 66 Mexico Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 67 Mexico Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 68 Mexico Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 69 Mexico Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 70 Mexico Wound Care Biologics, By End User, 2016-2025, (Usd Million)
List Of Figures
Figure 1 North America Wound Care Biologics Market: Segmentation
Figure 2 North America Wound Care Biologics Market: Data Triangulation
Figure 3 North America Wound Care Biologics Market: Research Snapshot
Figure 4 North America Wound Care Biologics Market: Bottom Up Approach
Figure 5 North America Wound Care Biologics Market: Top Down Approach
Figure 6 North America Wound Care Biologics Market: Interview Demographics
Figure 1 North America Wound Care Biologics Market: Dbmr Market Position Grid
Figure 2 North America Wound Care Biologics Market: The Market Challenge Matrix
Figure 3 Drivers, Restraints, Opportunities And Challenges Of North America Wound Care Biologics Market
Figure 4 Aging Population In Different Countries (2014, 2017 & 2020)
Figure 5 North America Wound Care Biologics Market: Segmentation
Figure 6 Increasing Prevelance Of Diabetic Foot Ulcers And Increasing Incidences Of Burn Cases Are Expected To Drive The Market For North America Wound Care Biologics In The Forecast Period 2018 To 2025
Figure 7 Synthetic Skin Grafts In North America Wound Care Biologics Is Expected To Account For The Largest Share Of The North America Wound Care Biologics Market In 2018 & 2025
Figure 8 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For North America Wound Care Biologics Market In The Forecast Period From 2018 To 2025
Figure 9 Worldwide Prevalence Of Various Wound Types, 2011
Figure 10 Cases Of Burn Injuries, (2009 – 2012)
Figure 11 Prevalence Of Pressure Ulcers In Few Countries
Figure 12 Number Of Surgical Procedures And Surgical Site Infections
Figure 13 North America Wound Care Biologics Market: By Product Type, 2017
Figure 14 North America Wound Care Biologics Market: By Wound Type, 2017
Figure 15 North America Wound Care Biologics Market: By End User, Snapshot 2017
Figure 16 North America Wound Care Biologics Market: Snapshot (2017)
Figure 17 North America Wound Care Biologics Market: By Country (2017)
Figure 18 North America Wound Care Biologics Market: By Country (2018 & 2025)
Figure 19 North America Wound Care Biologics Market, By Country (2017 & 2025)
Figure 20 North America Wound Care Biologics Market, By Product Type (2018 -2025)
Figure 21 North America Wound Care Biologics Market: Company Share 2017 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook